Daewoong Pharmaceutical Co. Ltd.
Clinical trials sponsored by Daewoong Pharmaceutical Co. Ltd., explained in plain language.
-
New version of ovarian cancer drug tested for safety and effectiveness
Disease control Recruiting nowThis study tests whether a new version of the drug olaparib (DWZ2501) works as well as the current version (DWC202510) in women with advanced BRCA-mutated ovarian cancer. About 40 participants will take both versions at different times to compare drug levels and safety. The goal …
Phase: PHASE1 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New study tests OLMETEC's effect on nighttime blood pressure in 12,000 koreans
Disease control Recruiting nowThis observational study will follow 12,000 Korean adults with stage 1 hypertension who are newly prescribed OLMETEC or OLMETEC Plus. The main goal is to see how well the medication controls blood pressure over 24 hours, especially at night. Participants will have their blood pre…
Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New autoimmune drug candidate takes first step in human tests
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called DWP212525 in 84 healthy adults aged 19 to 55. The main goal is to check safety and how the drug moves through the body. It is the first step in developing a possible treatment for autoimmune diseases.
Phase: PHASE1 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Early safety check for experimental drugs begins
Knowledge-focused Recruiting nowThis early-stage trial is testing the safety and how the body handles three experimental drugs—DWJ1622, DWC202313, and DWC202314—in 40 healthy adults. Participants take a single dose of each drug under fasting conditions. The study aims to measure drug levels in the blood and che…
Phase: PHASE1 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Healthy volunteers test new drug combinations in Early-Stage trial
Knowledge-focused Recruiting nowThis early-phase study is testing three experimental drugs (DWJ1622, DWC202313, and DWC202314) in 36 healthy adults. The goal is to see how the body absorbs and processes these drugs and to check for any safety issues. Participants will take the drugs by mouth after eating. This …
Phase: PHASE1 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC